Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
This study is looking at how safe and effective it is to use a magnetic tracer called FerroTrace and a fluorescent dye called Indocyanine Green to find lymph nodes where gastric cancer (stomach cancer) might have spread. You could be eligible if you are 18 or older, have gastric cancer that hasn't spread to distant parts of your body, and are having surgery to remove the cancer. The study aims to see if using FerroTrace and Indocyanine Green can help doctors better detect the disease. The study is currently unclear on its recruitment status and plans to enroll 20 participants.
- Study design
- This interventional study plans to enroll 20 participants and assigns them to one of two groups for receiving the study interventions.
- What's involved
- You would undergo gastrectomy (surgery to remove part or all of your stomach) and receive injections of FerroTrace and Indocyanine Green either before or during surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your safety will be assessed within 24 hours of the FerroTrace injection.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
At a glance
Conditions
NCT05038098
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
M D Anderson Cancer Center
Houston, Texasstudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Naruhiko Ikoma · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Safety of endoscopic peritumoral gastric injection of FerroTraceWithin 24 hours of the FerroTrace injection
The Bayesian method by Thall et al. will be applied for interim toxicity monitoring. Toxicities are defined as any grade III or greater toxicities attributable to FerroTrace injection, which occur within 24 hours of the injection. Will summarize the rate of adverse events (AEs) in all patients and by cohort, along with the exact 95% confidence interval.